Does EW's sales & support team provide any services to assist hospitals & surgical groups with training & staffing/consulting needed to offer this procedure?
It would be interesting to know who offers training & how well they are booked up.
Also; are their any quasi-channel checks on hiring of extra personnel by prospective Sapien clients?
I'd love to see that headline.
Here's the scenario:
Icahn invites Cook to dinner again thinking he'll get some for sure this time.
The table is set & Love is in the air.
Carl switches the tunes from ICP to smooth jazz.
During dinner uncle Carl slips his hand under the table & tries to rub Tim's leg & BAM!
Tim says "don't call me again" & Uncle Carl puts his Juggalo outfit back on & dumps his pos for a stake in Pfizer (hoping for discounts on Viagra…)
Uncle Carl is such a #$%$..
Oracle develops & markets software to help businesses manage customers, sales, inventories, processes & social networks (I'm sure I missed a few things but you get the idea.)
They are switching from purely software to offering cloud computing solutions which means they'll need to be able to port existing customers over to a cloud based model as time goes on & it appears as though they are already offering migration paths.
Cloud is important as it allows firms to extend the life of it's hardware by putting the load on remote computing power.
There's a few ways to do this; buy or lease your own cloud hardware & serve it up to users or use someone elses offsite cloud set up.
How cost effective is it to buy or lease as opposed to upgrading thousands of PC's / Macs & managing multiple software packages on all these units?
With cloud computing all software updates are performed at once & nobody gets left out & you can either repurpose or fire some IT guys (so productivity should be boosted.)
They are also using the Sun acquisition to develop software/hardware end to end solutions (hardware is a lot lower margin & sales have been off.)
Management has stated 3 years in a row that indirect hardware sales are hiher than direct sales & they want to change that (last quarters internal sales force had some issues closing sales & hopefully they'll get this ironed out through training & incentives.)
There have been no big wite downs or restatements in the wake of the Sun acquisition & the auditors continue to give unqualified opinions of financial statements & controls so that's a thumbs up!
I'm thinking it's a buy under $27.
$4B in FCF + share repurchases + divvie within next 2 years = value enhancement
Low capex & a merger that could actually work (Management teams often cite "synergies" when what they mean is "wishful thinking.")
In the case of ESRX & Medco; these are 2 business that truly complement each other as they do basically the same thing using different methods & generating different data sets.
In fact; Medco has a larger mail order biz which is more profitable for the company than simply processing pharmacy orders.
Mail order provides lower cost benefits to patients than those filled at a pharmacy.
I think ESRX is going to try & expand the list of drugs it can legally dispense through mail order over the next few years (the Amazon of pharma!)
There will more than likely be restatements of financials when the dust clears.
There will undoubtedly be unhappy employees during the digestion process.
There will also be new efficiencies in the combined entity.
ESRX goal is to improve physicians prescription recommendations (as opposed to being swayed by pharma sales reps) & to enhance patient drug use habits through subtle psychological shifts in the patients perceptions (did you ever wonder why drug companies spend sooooooo much money on TV ads?)
Resless leg syndrome - puleeeeze...
If the new ESRX can drive down drug costs & improve patient outcomes by using its massive data on costs versus efficacy; it will continue to generate strong FCF.
Please short this stock so I can buy more; cheaper!!!
This is not an asset based biz.
Neither is Oracle.
Positive earns & $4B in FCF.
Merger restatements coming.
Air will clear.
ESRX will confound shorts...
Would you like to borrow my shares?
Low capex & great free cash flow!
Modest growth by expanding mail order.
Improved margins after digesting Medco.
Increased share repurchases & dividend initiation after Medco merger reorganization (there's not much else can they spend all that FCF on...)
No business sustains high growth forever.
It's Paz' job now to NOT introduce "New Coke."
Thanks for your comments.
(Even the spammers are avoiding this board...)
By adjacent markets; do you mean mail order?
What other adjacencies do you see?
Tea baggers & left wing whack jobs.
All a bunch of reactive sheep who bleet the opinions of others.
Anyone want to generate some original conversation about Oracle?
Awesome; I'm steadily going back through old 10K's & various ancient article regarding negotiating a contract with a PBM.
I never would have thought back in high school that these kinds of things would fascinate me so much.
It seems to me that CVS could possibly be more effective for patients (if they are up to the task) since they face the consumer more closely & can evaluate outcomes better.
I still haven't read enough about Medco to know what they provide that is different than what ESRX already had (I suspect ESRX wanted the mail order volume but hope it was systems & data to improve patient outcomes.)
I believe improved efficacy of treatments will produce winning results in the long run.
(Am I being naive?)
Were you in the insurace industry in another life?
I've been long GLW since $12 for reasons of value.
I like a good fairy tale as much as the next guy but you are delusional if you think Apple is going to play monkey see monkey do.
Samsung has been producing chips for Apple for years now & you haven't seen Cook take a stake in Intel or any other manufacturer.
What makes you think he'd invest in production capacity for display glass?
Apple will continue to make small tuck in purchases of businesses which enhance it's core value proposition to end users (UI, mapping, media, social, ads & payments.)
Apple is not a manufacturer.
Apple is a creator that leaves the grunt work to lesser beings.
(I know this last will elicit groans from staunch B Gates lovers...)
What's he gonna do?
Sell his shares or shut up; that's what.
His purchase barely makes the needle move (except of course for the lemmings who follow him.)
I hope he makes a big splashy sell so Apple can continue the repurchase at a lower cost to shareholders.
I'd love to see it go sub $400 again!
Apple is NOT going to put capital into GLW.
Look at the ROIC as opposed to buying back their own shares.
They'd sooner buy Icahn a condo in Maui...